Patient-partner satisfaction with intracavernous medication supported with oral agents in selected cases of Peyronie's disease. A ten-month follow-up study.
We attempted to find the most adequate treatment option for some selected cases of Peyronie's disease. Between 1993 and 1996, 38 patients with Peyronie's disease and erectile dysfunction were treated with intracavernous medication, supported with oral colchicine and vitamin E. None of the cases had severe angulation of penis and intolerable pain during erection. Quality of sexual life was assessed by CWRU questionnaire. After ten-month follow-up we found improvement in all parameters, in CWRU. The symptoms of 24 cases diminished. The 21 partners examined were also satisfied with the therapy. We conclude that intracavernous medication combined with oral agents is a useful alternative treatment in selected cases of Peyronie's disease.
Culha
M
M
Department of Urology, Kocaeli University Faculty of Medicine, Turkey.
Mutlu
N
N
Acar
O
O
Alici
B
B
D000328:Adult; D000527:Alprostadil / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D004333:Drug Administration Routes; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000627:therapeutic use; D017060:Patient Satisfaction; D010411:Penile Induration / Q000188:drug therapy* / Q000523:psychology*; D010646:Phentolamine / Q000627:therapeutic use; D012747:Sexual Partners / Q000523:psychology; D014665:Vasodilator Agents / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D014665:Vasodilator Agents; D014810:Vitamin E; D010208:Papaverine; D000527:Alprostadil; D003078:Colchicine; D010646:Phentolamine